A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Inclusion Criteria: * Healthy adult volunteers aged 19 to 50 years at the time of screening. * Body mass index (BMI) between 18.0 and 30.0 kg/m², inclusive. * Male subjects must weigh ≥50 kg. * Female subjects must weigh ≥45 kg. * No clinically significant congenital or chronic diseases requiring treatment, based on medical history and physical examination. * Clinically acceptable results from laboratory tests (e.g., hematology, biochemistry, serology, urinalysis) and electrocardiogram (ECG) at screening, as determined by the investigator. * Willing to use medically accepted contraception (excluding hormonal methods) from the first dose until 7 days after the last dose, and agrees not to donate sperm or eggs during this period. * Able and willing to provide written informed consent after receiving a full explanation of the study. Exclusion Criteria: * Use of drugs known to induce or inhibit drug-metabolizing enzymes within 30 days prior to the first dose, or any medication likely to interfere with the study within 10 days prior to dosing. * Participation in any clinical trial involving investigational products within 6 months prior to the first dose. * Whole blood donation within 8 weeks, or component blood donation within 2 weeks prior to the first dose. * History of gastrointestinal surgery that may affect drug absorption (excluding appendectomy and hernia repair). * History of excessive alcohol consumption within 1 month prior to the first dose: * \>21 drinks/week for males, \>14 drinks/week for females (1 drink = 50 mL soju, 30 mL whiskey, or 250 mL beer) * Known hypersensitivity to any component of the investigational product. * Clinically significant renal, hepatic, cardiovascular, respiratory, metabolic, or infectious diseases, including but not limited to: * Moderate to severe renal impairment (eGFR or creatinine clearance \<45 mL/min) * Dialysis * Acute or unstable heart failure * Acute myocardial infarction, septicemia, or shock * Type 1 diabetes, metabolic acidosis, or history of diabetic ketoacidosis * Major surgery planned during the study (except minor procedures not affecting food or fluid intake) * Severe infections, trauma, or nutritional deficiencies * Positive pregnancy test or currently breastfeeding (for female subjects). * History of significant psychiatric illness. * Determined by the investigator to be unsuitable for the study for any other reason.